Ondine Biomedical, Inc. operates as a life sciences company that develops photodisinfection-based therapies to address drug-resistant infections. Its platform technology called antimicrobial photodynamic disinfection to help prevent and help treat infections across many therapeutic areas in healthcare and industry settings. The firm's novel, patented platform technology both reduces inflammation and eliminates harmful pathogens, rapidly destroying bacteria, fungi and viruses including superbugs and SARS-CoV-2. The company was founded by Carolyn Cross on September 9, 1996 and is headquartered in Vancouver, Canada.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company